Clinical Trial Update: Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC

View source ↗

Summary

A clinical trial evaluating different capecitabine regimens in patients with triple-negative breast cancer who did not achieve pathological complete response af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Shu Wang | Conditions: Triple Negative Breast Cancer | Status: RECRUITING